DHILLON PUNIT — SEC Form 4 filings
SEC reporting owner CIK 1425052. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-01 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 82,910 shares, $413,925 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 82,546 shares @ $4.99 ($411,905) in Skye Bioscience, Inc., filed 2024-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Skye Bioscience, Inc. (SKYE) | Chief Executive Officer, Director | 9 | — | 2 legs · 82,910 sh · $413,925 | 23 |
Form 4 filings — DHILLON PUNIT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 1,090,000 @ $0 | EDGAR |
| 2026-04-02 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 250,000 (derivative) · Disposition to issuer (D): 250,000 (derivative) · Grant/award (A): 36,000 (derivative) · Disposition to issuer (D): 36,000 (derivative) · Grant/award (A): 12,360 (derivative) · Disposition to issuer (D): 12,360 (derivative) · +8 more | EDGAR |
| 2026-02-09 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 280,000 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Skye Bioscience, Inc. (SKYE) | Sale (S): 364 @ $5.55 · Sale (S): 82,546 @ $4.99 | EDGAR |
| 2024-10-30 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | Skye Bioscience, Inc. (SKYE) | Other (J): 15,727 | EDGAR |
| 2024-03-04 | 4/A | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 100,000 @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 100,000 @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1425052 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →